Drugs / MM-10-001
last change May 2021 re-read 3 minutes ago

MM-10-001

Developed for
lung cancer
Investigated by
City of Hope Medical Center · National Cancer Institute (NCI)

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00857025 Nov 2008 → Nov 2010 lung cancer City of Hope Medical Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MM-10-001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00857025 ↗
Route Oral “Patients receive oral beta-glucan MM-10-001 once or twice daily.” NCT00857025 ↗